000 01141 a2200301 4500
005 20250516064106.0
264 0 _c20120628
008 201206s 0 0 eng d
022 _a1875-533X
024 7 _a10.2174/092986711798184316
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFerrarini, M
245 0 0 _aProteasome inhibitors and modulators of angiogenesis in multiple myeloma.
_h[electronic resource]
260 _bCurrent medicinal chemistry
_c2011
300 _a5185-95 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aEnzyme Inhibitors
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aMultiple Myeloma
_xblood supply
650 0 4 _aNeovascularization, Pathologic
_xdrug therapy
650 0 4 _aProteasome Inhibitors
700 1 _aFerrero, E
773 0 _tCurrent medicinal chemistry
_gvol. 18
_gno. 34
_gp. 5185-95
856 4 0 _uhttps://doi.org/10.2174/092986711798184316
_zAvailable from publisher's website
999 _c21315815
_d21315815